Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
about
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cellsIdentification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysisGraft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptorAdoptive T cell therapy: Addressing challenges in cancer immunotherapyNK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell TransplantationA New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem CellsNatural Killer Cells for Therapy of LeukemiaHow do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Haploidentical Transplantation in Children with Acute Leukemia: The Unresolved IssuesUnderground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsThe role of NK cells in HIV-1 protection: autologous, allogeneic or both?NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell EngraftmentCord Blood as a Source of Natural Killer CellsNatural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyNatural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivitySelection and expansion of natural killer cells for NK cell-based immunotherapyEffector Functions of Natural Killer Cell Subsets in the Control of Hematological MalignanciesAlloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive ImmunotherapyTrial Watch: Adoptive cell transfer for oncological indicationsImmune Modulation in Hematologic MalignanciesEnhancing Cancer Immunotherapy Via Activation of Innate ImmunityNK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer ImmunotherapyT-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effectNatural killer cell biology: an update and future directionsNatural killer cell regulation by microRNAs in health and diseasePost-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantationNK cell therapy: targeting disease relapse after hematopoietic stem cell transplantationImproving the outcome of leukemia by natural killer cell-based immunotherapeutic strategiesAdvantages and clinical applications of natural killer cells in cancer immunotherapyTumor-primed NK cells: waiting for the green lightImmunotherapy in the treatment of non-small cell lung cancerNeoplastic "Black Ops": cancer's subversive tactics in overcoming host defensesMaking the genomic leap in HCT: application of second-generation sequencing to clinical advances in hematopoietic cell transplantationPositive and negative regulation by NK cells in cancerKiller immunoglobulin-like receptors and tumor immunityChildhood acute myeloid leukaemiaInteraction between natural killer cells and regulatory T cells: perspectives for immunotherapyCurrent perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptorsAdvances in haplo-identical stem cell transplantation in adults with high-risk hematological malignanciesCellular immunotherapy for pediatric solid tumors
P2860
Q21245481-52BF42FD-DEF6-48EB-9A2C-A8095D3AD90AQ24562910-8BDAA426-D42D-4CC0-BFD0-E3281C3C5DE1Q24670205-65BA07F5-0080-414C-B7F9-CAE200EA7843Q24805804-70343853-CD07-440E-A899-338086E122BEQ26744632-EC1FD41A-E47B-4AFB-9041-66BDCF7DCA62Q26744651-CC5A379E-9367-4FBD-861B-5090D661CB0FQ26745906-754A03DA-CDBF-401F-BB10-389D2145A7FBQ26748867-ABE278CB-242D-4D30-9080-9B0097142BBAQ26750671-37B01411-9BC9-4D4C-A9B1-A38F37615DA6Q26751011-4A150130-E973-4EA3-B14A-9F1526BD33A1Q26753146-B4F14489-002C-4E52-88F6-4D0B6E6A336CQ26765845-8DC51A4A-9896-438C-827D-1BB1213D854FQ26771337-753C8073-EF3B-4604-8A97-7D609753F587Q26772347-DCA375EE-EE9F-4198-BF2A-6D35FA65ACC2Q26773135-D9270C86-0E55-4CDF-A88C-700F45228B93Q26774777-B35FE1AE-65DD-48DA-857E-34893278EC69Q26776538-72ED0D05-72FD-4558-9F7D-E2BB64B87451Q26777209-A845F138-0FC9-4CD1-998C-30226674A6C4Q26785545-9521333D-B297-4A11-A685-20C29DA6B1ECQ26796307-3633EB93-10DF-4CC6-BFF8-4405767C5454Q26796313-5D1D0DC8-7F7F-48B9-A424-DBFDC2A7D04BQ26797345-2287D6A8-8E6C-4FBA-8A3F-1E44BF4B083AQ26826830-30BEA937-F735-45BA-9943-F0719298DB4DQ26830512-40F8BEC2-A180-411E-9722-FEB57E84BB02Q26849448-60F35566-3B82-47BC-922F-36F072753406Q26852474-11A2C5AC-1390-47AA-B10F-FB9D6A826F98Q26863559-E7DA4183-AF53-4EB9-92AD-06A9B6B30FA5Q26996660-A7CF5D2F-B120-4DD0-B94C-1DCE4F302FBCQ26999224-AF14A696-4628-440B-8851-6EEF4FB1F5B3Q26999306-19D7245D-6164-4EE7-805A-187333FD3C58Q27000382-4F7FABBF-606D-4D4A-9E6B-9EAB6AF59CA7Q27001081-AE6114FB-D472-4056-BD7F-7C41FE44B4CDQ27002964-39CECC5D-91F9-4EE0-8EB0-ABD58C55E779Q27004658-4535C55F-7920-4DF5-B571-A082360A16DDQ27005792-A8557D87-B81D-48BF-BC62-3EB62320E6E9Q27005960-064B63D2-5A26-4234-9149-88C96CEEBF8BQ27008625-662D4940-4871-49CC-A500-ADA8B89F81D7Q27009135-A62D03AE-6099-48A1-9176-B5F03C59AEC5Q27014857-82D6D4DE-FC9A-4E4D-BEEF-201A7F1CFEFBQ27014912-770E9158-06AB-4602-B620-32296FE91482
P2860
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
description
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Science
@fr
artículu científicu espublizáu en 2002
@ast
im März 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 15 March 2002)
@en
wetenschappelijk artikel (gepubliceerd op 2002/03/15)
@nl
наукова стаття, опублікована в березні 2002
@uk
مقالة علمية (نشرت في 15-3-2002)
@ar
name
Effectiveness of donor natural ...... ched hematopoietic transplants
@ast
Effectiveness of donor natural ...... ched hematopoietic transplants
@en
type
label
Effectiveness of donor natural ...... ched hematopoietic transplants
@ast
Effectiveness of donor natural ...... ched hematopoietic transplants
@en
prefLabel
Effectiveness of donor natural ...... ched hematopoietic transplants
@ast
Effectiveness of donor natural ...... ched hematopoietic transplants
@en
P2093
P3181
P356
P1433
P1476
Effectiveness of donor natural ...... ched hematopoietic transplants
@en
P2093
Andrea Velardi
Antonella Tosti
Daniela Rogaia
Elena Urbani
Katia Perruccio
Loredana Ruggeri
Marusca Capanni
Massimo F Martelli
Sabrina Posati
Warren D Shlomchik
P304
P3181
P356
10.1126/SCIENCE.1068440
P407
P577
2002-03-01T00:00:00Z